Menu

• Ask a Health Expert about GLOMERULONEPHRITIS MEMBRANOUS
• Post Your Side Effect related to GLOMERULONEPHRITIS MEMBRANOUS
• GLOMERULONEPHRITIS MEMBRANOUS and FDA Warnings
• GLOMERULONEPHRITIS MEMBRANOUS in Patients Wiki
• Report GLOMERULONEPHRITIS MEMBRANOUS in Drug Side Effect Survey

GLOMERULONEPHRITIS MEMBRANOUS side effect

What is GLOMERULONEPHRITIS MEMBRANOUS ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Cyclosporine Side Effects Report #5657336-6
Consumer or non-health professional from JAPAN reported CYCLOSPORINE problem on Feb 27, 2008. Male patient, 14 years of age, was diagnosed with stem cell transplant and was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: glomerulonephritis membranous, herpes zoster disseminated, . CYCLOSPORINE dosage: unknown. During the same period patient was treated with METHOTREXATE. Patient recovered.

Rosuvastatin Side Effects Report #5634746-4
ROSUVASTATIN problem was reported by a Pharmacist from UNITED STATES on Feb 21, 2008. Male patient, 67 years of age, weighting 280.0 lb, was diagnosed with hypercholesterolaemia and was treated with ROSUVASTATIN. After drug was administered, patient experienced the following problems/side effects: glomerulonephritis membranous, renal failure chronic, . ROSUVASTATIN dosage: 20MG HS PO. Patient recovered.

Azulfidine Side Effects Report #5583348-7
Health Professional from JAPAN reported AZULFIDINE EN problem on Dec 27, 2007. Male patient, weighting 132.3 lb, was diagnosed with rheumatoid arthritis, hypertension and was treated with AZULFIDINE EN. After drug was administered, patient experienced the following problems/side effects: glomerulonephritis membranous, iga nephropathy, nephrotic syndrome, platelet count decreased, . AZULFIDINE EN dosage: unknown. During the same period patient was treated with AMLODIN, SOLETON, OLMETEC. Patient was hospitalized. Patient recovered.

Olmesartan Side Effects Report #5589402-8
OLMESARTAN MEDOXOMIL problem was reported by a Consumer or non-health professional from JAPAN on Dec 27, 2007. Male patient, 68 years of age, weighting 132.3 lb, was diagnosed with hypertension, rheumatoid arthritis and was treated with OLMESARTAN MEDOXOMIL. After drug was administered, patient experienced the following problems/side effects: glomerulonephritis membranous, iga nephropathy, infection, lung neoplasm malignant, nephrotic syndrome, platelet count decreased, rheumatoid arthritis, thrombocytopenia, . OLMESARTAN MEDOXOMIL dosage: 20 MG (10 MG, 2 IN 1 D), PER ORAL. During the same period patient was treated with AZULFIDINE EN, SOLETON, AMLODIN. Patient was hospitalized. Patient recovered.


Azulfidine Side Effects Report #5536243-3
Physician from JAPAN reported AZULFIDINE EN problem on Nov 20, 2007. Male patient, weighting 132.3 lb, was diagnosed with rheumatoid arthritis, hypertension and was treated with AZULFIDINE EN. After drug was administered, patient experienced the following problems/side effects: glomerulonephritis membranous, iga nephropathy, nephrotic syndrome, thrombocytopenia, . AZULFIDINE EN dosage: unknown. During the same period patient was treated with AMLODIN, SOLETON, OLMETEC. Patient was hospitalized. Patient recovered.

Olmesartan Side Effects Report #5557382-7
OLMESARTAN MEDOXOMIL problem was reported by a Consumer or non-health professional from JAPAN on Nov 27, 2007. Male patient, 68 years of age, weighting 132.3 lb, was diagnosed with hypertension and was treated with OLMESARTAN MEDOXOMIL. After drug was administered, patient experienced the following problems/side effects: glomerulonephritis membranous, iga nephropathy, nephrotic syndrome, thrombocytopenia, . OLMESARTAN MEDOXOMIL dosage: 20 MG (10 MG,2 IN 1 D), PER ORAL. During the same period patient was treated with AZULFIDINE EN, SOLETON. Patient was hospitalized. Patient recovered.

Azulfidine Side Effects Report #5577306-6
Health Professional from JAPAN reported AZULFIDINE EN problem on Dec 14, 2007. Male patient, weighting 132.3 lb, was diagnosed with rheumatoid arthritis, hypertension and was treated with AZULFIDINE EN. After drug was administered, patient experienced the following problems/side effects: glomerulonephritis membranous, iga nephropathy, nephrotic syndrome, platelet count decreased, . AZULFIDINE EN dosage: unknown. During the same period patient was treated with AMLODIN, SOLETON, OLMETEC. Patient was hospitalized. Patient recovered.

Olmesartan Side Effects Report #5581204-1
OLMESARTAN MEDOXOMIL problem was reported by a Consumer or non-health professional from JAPAN on Dec 14, 2007. Male patient, 68 years of age, weighting 132.3 lb, was diagnosed with hypertension, rheumatoid arthritis and was treated with OLMESARTAN MEDOXOMIL. After drug was administered, patient experienced the following problems/side effects: glomerulonephritis membranous, iga nephropathy, lung neoplasm malignant, nephrotic syndrome, platelet count decreased, rheumatoid arthritis, . OLMESARTAN MEDOXOMIL dosage: 20 MG (10 MG, 2 IN 1 D), PER ORAL. During the same period patient was treated with AZULFIDINE EN, SOLETON, AMLODIN. Patient was hospitalized. Patient recovered.

Azulfidine Side Effects Report #5530968-1
Physician from JAPAN reported AZULFIDINE EN problem on Nov 20, 2007. Male patient, weighting 132.3 lb, was diagnosed with rheumatoid arthritis, hypertension and was treated with AZULFIDINE EN. After drug was administered, patient experienced the following problems/side effects: glomerulonephritis membranous, iga nephropathy, nephrotic syndrome, thrombocytopenia, . AZULFIDINE EN dosage: unknown. During the same period patient was treated with SOLETON, OLMETEC, AMLODIN. Patient was hospitalized. Patient recovered.


Cyclosporine Side Effects Report #5476600-7
CYCLOSPORINE problem was reported by a Consumer or non-health professional from JAPAN on Sept 26, 2007. Male patient, 29 years of age, was diagnosed with bone marrow transplant and was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: glomerulonephritis membranous, renal vessel disorder, . CYCLOSPORINE dosage: unknown. During the same period patient was treated with ENDOXAN. Patient recovered.

Neoral Side Effects Report #5484079-4
Consumer or non-health professional from JAPAN reported NEORAL problem on Oct 03, 2007. Male patient, 29 years of age, was diagnosed with bone marrow transplant and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: glomerulonephritis membranous, haematuria, platelet count decreased, proteinuria, renal vessel disorder, urine abnormality, white blood cell count decreased, . NEORAL dosage: 200 MG/DAY. During the same period patient was treated with ENDOXAN. Patient recovered.

Effexor Side Effects Report #5486982-8
EFFEXOR problem was reported by a Health Professional from FRANCE on Oct 08, 2007. Female patient, 56 years of age, was treated with EFFEXOR. After drug was administered, patient experienced the following problems/side effects: glomerulonephritis membranous, hepatitis cholestatic, impetigo, . EFFEXOR dosage: unknown. During the same period patient was treated with TAHOR, PREDNISONE, ALDACTONE, LEVOTHYROX, LASIX, CHLORAMBUCIL, TRIATEC. Patient was hospitalized. Patient recovered.

Hypen Side Effects Report #5446253-2
Health Professional from JAPAN reported HYPEN problem on Sept 04, 2007. Female patient, 56 years of age, was diagnosed with arthralgia and was treated with HYPEN. After drug was administered, patient experienced the following problems/side effects: glomerulonephritis membranous, musculoskeletal stiffness, . HYPEN dosage: unknown. Patient was hospitalized. Patient recovered.

Etodolac Side Effects Report #5402304-2
ETODOLAC problem was reported by a Health Professional from JAPAN on July 23, 2007. Female patient, 56 years of age, was diagnosed with rheumatoid arthritis and was treated with ETODOLAC. After drug was administered, patient experienced the following problems/side effects: glomerulonephritis membranous, musculoskeletal stiffness, . ETODOLAC dosage: unknown. Patient was hospitalized. Patient recovered.


Rebif Side Effects Report #5413342-8
Physician from AUSTRALIA reported REBIF problem on July 30, 2007. Female patient, weighting 165.3 lb, was diagnosed with multiple sclerosis and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: glomerulonephritis membranous, . REBIF dosage: unknown. Patient recovered.

Benemid Side Effects Report #5420974-X
BENEMID problem was reported by a Health Professional from FRANCE on Aug 15, 2007. Male patient, 79 years of age, was diagnosed with gout and was treated with BENEMID. After drug was administered, patient experienced the following problems/side effects: glomerulonephritis membranous, nephrotic syndrome, pitting oedema, weight increased, . BENEMID dosage: unknown. Patient was hospitalized. Patient recovered.

Probenecid Side Effects Report #5421889-3
Consumer or non-health professional from FRANCE reported PROBENECID problem on Aug 03, 2007. Male patient, 79 years of age, was diagnosed with gout and was treated with PROBENECID. After drug was administered, patient experienced the following problems/side effects: glomerulonephritis membranous, nephrotic syndrome, . PROBENECID dosage: 500 MG; TWICE A DAY; ORAL; 1500 MG; DAILY; ORALQ. Patient was hospitalized. Patient recovered.

Azulfidine Side Effects Report #5759009-8
AZULFIDINE EN problem was reported by a Physician from JAPAN on May 28, 2008. Male patient, weighting 99.21 lb, was diagnosed with rheumatoid arthritis, gastric ulcer, diabetes mellitus, osteoporosis and was treated with AZULFIDINE EN. After drug was administered, patient experienced the following problems/side effects: glomerulonephritis membranous, . AZULFIDINE EN dosage: unknown. During the same period patient was treated with PREDNISOLONE, SOLETON, MUCOSTA, AMARYL, LANSOPRAZOLE, BASEN, ALENDRONATE. Patient was hospitalized. Patient recovered.

Prednisone Side Effects Report #5774474-8
Consumer or non-health professional from reported PREDNISONE problem on June 09, 2008. Male patient, 33 years of age, was diagnosed with hypereosinophilic syndrome and was treated with PREDNISONE. After drug was administered, patient experienced the following problems/side effects: glomerulonephritis membranous, nephrotic syndrome, oedema peripheral, . PREDNISONE dosage: 60 MG AT STUDY ENTRY, TAPERED TO 20 MG, SUBSEQUENTLY INCREASED TO 30 MG. During the same period patient was treated with LORCET, GLIPIZIDE, LISINOPRIL, SIMVASTATIN, FUROSEMIDE, HYZAAR. Patient was hospitalized. Patient recovered.


Prednisone Side Effects Report #5691087-7
PREDNISONE problem was reported by a Consumer or non-health professional from on Mar 28, 2008. Male patient, 33 years of age, was diagnosed with hypereosinophilic syndrome and was treated with PREDNISONE. After drug was administered, patient experienced the following problems/side effects: glomerulonephritis membranous, nephrotic syndrome, oedema peripheral, . PREDNISONE dosage: 60 MG AT STUDY ENTRY, TAPERED TO 20 MG, SUBSEQUENTLY INCREASED TO 30 MG. During the same period patient was treated with LORCET, GLIPIZIDE, LISINOPRIL, SIMVASTATIN, FUROSEMIDE, HYZAAR. Patient was hospitalized. Patient recovered.

Azulfidine Side Effects Report #5693888-8
Physician from JAPAN reported AZULFIDINE EN problem on Mar 26, 2008. Male patient, weighting 99.21 lb, was diagnosed with rheumatoid arthritis, gastric ulcer, diabetes mellitus, osteoporosis and was treated with AZULFIDINE EN. After drug was administered, patient experienced the following problems/side effects: glomerulonephritis membranous, . AZULFIDINE EN dosage: unknown. During the same period patient was treated with PREDNISOLONE, SOLETON, MUCOSTA, AMARYL, TAKEPRON, BASEN, ALENDRONATE. Patient was hospitalized. Patient recovered.

Aranesp Side Effects Report #5313883-8
ARANESP problem was reported by a Health Professional from UNITED STATES on Apr 23, 2007. Male patient, 61 years of age, was diagnosed with anaemia and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: glomerulonephritis membranous, nephrogenic fibrosing dermopathy, nephrotic syndrome, . ARANESP dosage: unknown. Patient recovered.

Fluconazole Side Effects Report #5330541-4
Consumer or non-health professional from KOREA, REPUBLIC OF reported FLUCONAZOLE problem on May 01, 2007. Female patient, 58 years of age, was diagnosed with tinea pedis and was treated with FLUCONAZOLE. After drug was administered, patient experienced the following problems/side effects: glomerulonephritis membranous, nephrotic syndrome, . FLUCONAZOLE dosage: 150 MG /WEEK. During the same period patient was treated with AMLODIPINE, VALSARTAN, TORASEMIDE, HYDROCHLOROTHIAZIDE, METOCLOPRAMIDE, LEVOPRIDE. Patient was hospitalized. Patient recovered.

Cyclosporine Side Effects Report #5290781-X
CYCLOSPORINE problem was reported by a Physician from AUSTRALIA on Apr 04, 2007. Male patient, weighting 269.6 lb, was diagnosed with prophylaxis against transplant rejection and was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: glomerulonephritis membranous, . CYCLOSPORINE dosage: unknown. Patient was hospitalized. Patient recovered.

Fluconazole Side Effects Report #5256700-7
Consumer or non-health professional from KOREA, REPUBLIC OF reported FLUCONAZOLE problem on Feb 22, 2007. Female patient, 58 years of age, was diagnosed with tinea pedis and was treated with FLUCONAZOLE. After drug was administered, patient experienced the following problems/side effects: glomerulonephritis membranous, . FLUCONAZOLE dosage: unknown. During the same period patient was treated with AMLODIPINE, HYDROCHLOROTHIAZIDE, METOCLOPRAMIDE, LEVOSULPIRIDE. Patient recovered.

Sandimmune Side Effects Report #5476581-6
SANDIMMUNE problem was reported by a Consumer or non-health professional from JAPAN on Sept 26, 2007. Male patient, 54 years of age, weighting 121.3 lb, was diagnosed with bone marrow transplant and was treated with SANDIMMUNE. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, glomerulonephritis membranous, graft versus host disease, hypoaesthesia oral, nephropathy toxic, nephrotic syndrome, protein urine present, rash, renal disorder, . SANDIMMUNE dosage: 3 MG/KG/D. During the same period patient was treated with NEORAL. Patient recovered.

Sandimmune Side Effects Report #5486296-6
Consumer or non-health professional from JAPAN reported SANDIMMUNE problem on Oct 05, 2007. Male patient, 54 years of age, weighting 121.3 lb, was diagnosed with bone marrow transplant and was treated with SANDIMMUNE. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, glomerulonephritis membranous, graft versus host disease, hepatocellular damage, hypoaesthesia oral, nephropathy toxic, nephrotic syndrome, protein urine present, rash, . SANDIMMUNE dosage: 3 MG/KG/D. During the same period patient was treated with NEORAL. Patient recovered.

Sandimmune Side Effects Report #5489056-5
SANDIMMUNE problem was reported by a Consumer or non-health professional from JAPAN on Oct 05, 2007. Male patient, 54 years of age, weighting 121.3 lb, was diagnosed with bone marrow transplant and was treated with SANDIMMUNE. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, glomerulonephritis membranous, graft versus host disease, hepatocellular damage, hypoaesthesia oral, nephropathy toxic, nephrotic syndrome, protein urine present, rash, . SANDIMMUNE dosage: 3 MG/KG/D. During the same period patient was treated with NEORAL. Patient recovered.

Etodolac Side Effects Report #5397321-5
Consumer or non-health professional from JAPAN reported ETODOLAC problem on July 09, 2007. Female patient, 56 years of age, was diagnosed with rheumatoid arthritis and was treated with ETODOLAC. After drug was administered, patient experienced the following problems/side effects: blood cholesterol increased, glomerulonephritis membranous, oedema peripheral, proteinuria, . ETODOLAC dosage: 400MG, QD, ORAL. Patient was hospitalized. Patient recovered.

Etodolac Side Effects Report #5397321-5
ETODOLAC problem was reported by a Consumer or non-health professional from JAPAN on July 09, 2007. Female patient, 56 years of age, was diagnosed with rheumatoid arthritis and was treated with ETODOLAC. After drug was administered, patient experienced the following problems/side effects: blood cholesterol increased, glomerulonephritis membranous, oedema peripheral, proteinuria, . ETODOLAC dosage: 400MG, QD, ORAL. Patient was hospitalized. Patient recovered.

Rasilez Side Effects Report #5699716-9
Physician from reported RASILEZ problem on Apr 03, 2008. Male patient was diagnosed with hypertension and was treated with RASILEZ. After drug was administered, patient experienced the following problems/side effects: biopsy kidney abnormal, glomerulonephritis membranous, glucose tolerance test abnormal, glycosylated haemoglobin increased, haematuria, hyperkalaemia, metabolic syndrome, proteinuria, . RASILEZ dosage: unknown. During the same period patient was treated with ACETYLSALICYLIC ACID SRT, ALLOPURINOL, ATENOLOL, TROMCARDINTE, ENALAPRIL MALEATE, TOREM, CARMEN, NOVALGIN. Patient recovered.

Rasilez Side Effects Report #5716428-3
RASILEZ problem was reported by a Physician from on Apr 21, 2008. Male patient, 75 years of age, weighting 187.4 lb, was diagnosed with hypertension, hyperuricaemia and was treated with RASILEZ. After drug was administered, patient experienced the following problems/side effects: biopsy kidney abnormal, glomerulonephritis membranous, glucose tolerance test abnormal, glycosylated haemoglobin increased, haematuria, hyperkalaemia, metabolic syndrome, protein total decreased, proteinuria, . RASILEZ dosage: unknown. During the same period patient was treated with ACETYLSALICYLIC ACID SRT, ALLOPURINOL, ATENOLOL, TROMCARDINTE, TOREM, CARMEN, NOVALGIN, DOXAZOSIN MESYLATE. Patient recovered.

Fluconazole Side Effects Report #5420596-0
Consumer or non-health professional from KOREA, REPUBLIC OF reported FLUCONAZOLE problem on July 20, 2007. Female patient, 58 years of age, was diagnosed with tinea pedis and was treated with FLUCONAZOLE. After drug was administered, patient experienced the following problems/side effects: blood pressure increased, dyspepsia, glomerulonephritis membranous, nausea, . FLUCONAZOLE dosage: 21,4286 MG (150 MG, INTERMITTENTLY). During the same period patient was treated with AMLODIPINE, HYDROCHLOROTHIAZIDE, METOCLOPRAMIDE HYDROCHLORIDE, LEVOSULPIRIDE. Patient recovered.

Cyclosporine Side Effects Report #5703748-1
CYCLOSPORINE problem was reported by a Health Professional from ITALY on Apr 04, 2008. Female patient, 68 years of age, was diagnosed with stem cell transplant and was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: blood albumin decreased, creatinine renal clearance decreased, glomerulonephritis membranous, hypertensive crisis, nephropathy toxic, nephrotic syndrome, proteinuria, renal impairment, . CYCLOSPORINE dosage: unknown. During the same period patient was treated with STEROIDS NOS. Patient recovered.

Tice Side Effects Report #5305731-7
Consumer or non-health professional from INDIA reported TICE BCG problem on Apr 05, 2007. Male patient, 54 years of age, was diagnosed with transitional cell carcinoma and was treated with TICE BCG. After drug was administered, patient experienced the following problems/side effects: blood cholesterol increased, blood pressure increased, glomerulonephritis membranous, nephrotic syndrome, . TICE BCG dosage: 120 MG WEEKLY/120 MG OM INTRAVESICAL. Patient recovered.